Vasoactive intestinal peptide and bipolar affective illness. Evidence for an effect of lithium |
| |
| Authors: | W H Berrettini J I Nurnberger P Hotvedt S Simmons-Alling E S Gershon |
| |
| Institution: | 1. Section on Psychogenetics, Biological Psychiatry Branch, National Institute of Mental Health, Bldg. 10, Rm. 3N218, Bethesda, MD 20205, USA;2. Middlebury College, Middlebury, VT, U.S.A. |
| |
| Abstract: | In an attempt to evaluate the role of VIP in affective disorder, measurements of lymphocyte VIP receptors, and plasma and CSF VIP levels were made in unmedicated and lithium-treated euthymic bipolars and controls. Lithium decreased plasma (P = 0.01) and CSF (P = 0.05) VIP levels and increased the affinity (decreased the KD) of the VIP lymphocyte receptor (P less than 0.01). This effect may be relevant to the psychotropic action of lithium in manic-depressive illness. |
| |
| Keywords: | Bipolar affective illness - Lithium - Vasoactive intestinal peptide (VIP) |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
